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Feature Articles 
AIDS Update 
Evelyn J. Fisher, MD* 
The acquired immunodeficiency syndrome (AIDS) vims is now called the human immunodeficiency vims (HIV). By 
attacking the immune and nervous systems, HIV causes a broad 
range of disease ranging from none to fatal. The fatal illness 
AIDS represents end-stage disease of the immune system. How-
ever, at any given time for every one person with the fatal illness 
there may be 50 to IOO infected people who have no or milder 
illness. 
The manifestations of HIV infection are both primary, those 
due directly to the virus itself, and secondary, those due to 
immune damage. The secondary manifestations were the first 
recognized and are characteristic of immune deficiencies in 
general. These are: I) infections, including opportunistic infec-
tions; 2) tumors, including certain "opportunistic" tumors such 
as Kaposi's sarcoma and lymphomas (both of which also occur 
in transplant patients); and 3) other phenomena of immune 
dysregulation including autoimmune phenomena, of which 
thrombocytopenic purpura is the most common. The primary 
manifestations of HIV infection have been recognized only 
recently, and it is likely that more remain to be defined. Two 
well-recognized manifestations are 1) an acute infectious-mono-
nucleosis-Iike illness that occurs within one to eight weeks of 
initial infection, and 2) a spectrum of neurological illness. 
Neurologic symptoms may occur as an acute transient process 
shortly after infection or at any time during the course of the dis-
ease. Other manifestations that may prove to be due to HIV itself 
include interstitial pneumonia and gastrointestinal disorders, 
particularly diarrhea.HIV has been shown to infect certain cells 
in the body—the T-helper lymphocytes, the monocyte/mac-
rophages, and some central nervous system cells. It is not clear 
to what extent other cells in the body are infected, such as 
B-lymphocytes and intestinal cells. There is a recent description 
of in vitro infection of primary colonic epithelium. 
The HIV attack on the immune system is especially devastat-
ing because it strikes the "commander" of the immune system, 
the T-helper lymphocyte, as well as "frontline troops," the 
monocytes/macrophages, which are the antigen-processing and 
presenting cells. Since the T-helper lymphocyte controls at least 
six other reactions in the immune system, including most B-cell 
function, immune deficiency due to HIV involves much more 
than cell-mediated immunity. Thus HIV can cause immune defi-
ciency more profound than that of any other acquired form of 
immune deficiency and is comparable only to that of congenital 
severe combined immunodeficiency (SCID). Unlike SCID, 
however, one cannot save AIDS patients by shielding them in a 
"bubble" because they already have acquired the latent oppor-
tunistic pathogens that will kill them. Bone marrow transplanta-
tion has yet to be successful in AIDS. 
Virology 
Retroviruses, the family to which the AIDS virus belongs, 
are RNA viruses. They make a DNA copy of themselves by a 
unique enzyme, reverse transcriptase. This DNA copy, the 
provirus, inserts itself (ie, becomes integrated) into the chro-
mosomes of certain host cells; thus, infection is generally life-
long. Retroviruses can cause a range of effects: none, latent 
infection, cell damage, malignant transformation, or cell death. 
Retroviruses produce proteins that are transaciivating. These 
iransactivating factors can affect the function of adjacenl and 
distant genes on the chromosome at the level of bolh transcrip-
tion (the making of RNA from DNA) and translation (the mak-
ing of proteins from RNA). Transactivaling factors can increase 
the activity of other genes by a thousandfold or more. In fact, 
retroviral Iransactivating factors are being used to study the gene 
products of many different cells. 
Relrovimses are divided into three groups: the oncovimses 
(tumor-producing), the lentiviruses (slow viruses), and the 
spumaviruses (foamy viruses). HIV belongs to the second 
group, the lentiviruses. The first recognized human retro-
viruses, HTLV-I and HTLV-II, as well as most known animal 
retroviruses (starting wilh Rous' sarcoma described in 19n) are 
oncovimses—that is, they directly produce malignant transfor-
mation of infected cells. On the other hand, HIV is not itself 
oncogenic. The malignancies characteristic of AIDS probably 
result from other common vimses acting "opportunistically" 
oncogenic due to the immune deficiency. For example, the B-
cell lymphomas which occur in AIDS (and transplant patients) 
are probably caused by the Epstein-Barr virus. Kaposi's sar-
coma may possibly be due to cytomegalovims. 
In a sense, the lentivimses are worse than the oncovimses. 
The prototype of the lentivims group is visna, a neurologic dis-
ease of sheep. Despite the economic importance of this infec-
tion, efforts to develop a vaccine have failed for over a decade. 
The visna virus constantly modifies its antigens thus eluding the 
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host immune system. In this respect HIV closely resembles the 
visna vims, which implies similar difficulties in developing a 
HIV vaccine. The only successful retroviral vaccine developed 
to date is for an oncovims, that of feline leukemia. Feline leuke-
mia is different from HIV disease in that some cats develop a 
natural immunity to this disease. It is unlikely that a vaccine or 
cure for HIV infection will be developed in less than five to ten 
years and it could take 20 or more years. Because the HIV DNA 
provirus becomes part of the genome of lymphocytes, mono-
cytes, and perhaps other cells, tme cure requires the ability to 
excise parts of human DNA. 
AIDS is a disease that is going to be with us for a generation or 
more. Most Americans will never catch HIV, but most will 
come to have personal experience with the disease through 
someone they know—a family member, friend, or co-worker. 
No health care worker will be able to avoid caring for HIV-in-
fected persons. HIV infection will saturate those populations 
where people continue high-risk behavior and where infection 
rates are already very high—certain homosexual/bisexual men 
and intravenous dmg abusers. The infection will spread, proba-
bly more slowly but inexorably, as a sexually transmitted dis-
ease in the general heterosexual population. The challenge is to 
curtail its spread and control the accompanying epidemic as 
well, that of AIDS hysteria. 
AIDS Hysteria 
AIDS hysteria is as alarming as AIDS itself. Unfortunately, 
AIDS hysteria is still socially acceptable in our country, while 
hysterical behavior in any other potentially life-threatening sit-
uation is not. Even many health care professionals regard it as 
"reasonable" to refuse to treat AIDS patients. The first step in 
combating hysteria is to understand how HIV may have origi-
nated. Diabolical as HIV seems, it appears to be just another one 
of Mother Nature's nasty tricks. 
The current best hypothesis is that HIV arose perhaps 30 to 40 
years ago in central Africa from a mutation of a very similar sim-
ian vims, STLV-III. The STLV-III vims is found in the African 
Green monkey which associates closely with man and is killed 
by man for food. The most likely route of transmission to man 
may have been through skin cuts during the butchering process. 
In Africa infection may have originated as a rare mral disease; 
then, through population shifts, it became what it is today, a 
common urban disease. 
The next step in tackling AIDS hysteria is to acknowledge two 
very deep-seated irrational fears of man: the fear of contagion 
and the fear of homosexuality. Because of personal experience 
with highly contagious infections like the common cold and the 
history of epidemics of influenza, smallpox, and plague, most 
people believe that all infections are easy to catch, and they fear 
being around anyone with an infection of any kind. It is very 
difficult to convince people that some infections, such as HIV, 
are very difficult to catch. 
Homophobia, the fear of and prejudice against homosex-
uality, is prevalent in our society. Yet sexual preference seems to 
be acquired at a very early age, may even be genetic, and almost 
never can be changed. About 10% of our fellow humans are 
homosexual or bisexual. This includes 10% of our sons, grand-
sons, brothers, and male friends and co-workers. Nevertheless, 
homosexuality is still taboo and illegal in most areas. The homo-
sexuality of one's own sex is more threatening than that of the 
opposite sex. Thus heterosexual males may have more difficulty 
in dealing with AIDS. Unconsciously, men may feel that show-
ing any interest in HIV disease or placing themselves at the 
slightest risk of catching it might make some people think that 
they are homosexual. Often the husbands and boyfriends of 
female health care workers will strongly object to their working 
with AIDS patients and will insist that the women wash and 
change clothes completely before coming home. 
The dangers of letting hysteria remain unchecked are under-
appreciated by most people who are unaware of the barbaric 
outcome of uncontrolled social and religious hysteria in human 
history. The idea that disease is God's punishment is a powerful 
and pervasive human belief. Two theories are commonly in-
voked. The first theory is that the disease, such as AIDS, is 
God's punishment on a certain individual for his or her sins. 
This theory does not explain 1) the infection of "innocent vic-
tims" such as children, or 2) why both heterosexuals and male 
homosexuals are affected and lesbians are not. The second the-
ory is much more dangerous: the disease is God's punishment on 
all of us because of the sins of some of us (those "some" being 
"sinners" and "heretics"). This is the theory that has led in the 
past to mass murder. For example, during plague epidemics in 
the Middle Ages the common response was for Christians to 
slaughter Jews in the belief that the presence of these heretics 
had angered God and caused Him to bring the disease upon 
everyone. The Spanish Inquisition carried this concept of erad-
ication of heretics to its extreme, but was not successful in 
ridding Spain of disease. 
Hysteria is harmful because it wastes tremendous amounts of 
time, money, and energy which are needed to fight the real 
epidemic of AIDS. The medical consequences of this hy.steria 
include 1) shortage of blood donations (the number of blood do-
nations is still significantly less than before AIDS, since people 
still wrongly believe that AIDS can be acquired by giving 
blood); 2) undemse of the valuable hepatitis B vaccine; and 3) 
refusal of patients to accept necessary blood transfusions. Incal-
culable is the amount of unnecessary emotional stress on both 
patients and staff that is caused by this hysteria. 
The final step in dealing with hysteria is for people to be re-
ceptive to the actual data on transmission of HIV. The public as 
well as medical personnel still have many misconceptions re-
garding HIV transmission. There is confusion over the incuba-
tion period and unfamiliarity with transmission data regarding 
the large numbers of household contacts and health care workers 
who have been studied and who have tested negative for HIV. 
AIDS Incubation 
Confusion over the incubation period is understandable since 
there are actually five incubation periods which are pertinent to 
HIV infection. They involve the time from becoming infected 
with HIV to 1) viremia and potential contagiousness, 2) anti-
body (test) positivity, 3) acute illness, 4) symptoms of any kind, 
and 5) AIDS itself. A common misconception is to mistake in-
cubation period #5 for #2; that is, many think that it will take 
6 Henry Ford Hosp Med J—Vol 35, No 1, 1987 AIDS Update—Fisher 
five years to detect if anyone has been infected with the AIDS 
vims after being exposed to it, but actually the antibody test pro-
vides the information usually within three months of exposure. 
Our current knowledge of these incubation periods suggests the 
following time table: 
1. Time to viremia (hence potential contagiousness through 
blood and sex): one to three weeks. 
2. Time to antibody positivity (time for the blood test to 
become positive): usually between two to three months, occa-
sionally longer, possibly up to six to 12 months. 
3. Time between infection and the transient acute illness 
(which may be infectious-mononucleosis-like or neurologic): 
one to eight weeks. 
4. Time to development of any sort of symptoms: one week to 
indefinitely. 
5. Time to development of full-blown AIDS (fatal disease): 
six months to seven or more years, averaging five or more years 
in adults; zero (birth) to seven years in perinatal infection, aver-
aging one and one-half to two years in infants. 
The last incubation period, the time to development of fatal 
disease, is probably still being underestimated. HIV infection is 
lifelong in most persons, and it appears that the risk of fatal dis-
ease exists throughout the life of the infected person. We do not 
know what percent of infected people will eventually develop 
AIDS, but it may be a large percentage, perhaps as many as 50% 
or more by ten years after infection and an unknown percent 
beyond that time. 
TVansmission of AIDS 
Sexual relations 
HIV infection is in nature a sexually transmitted disease of 
human beings. There is nothing unique about homosexuality 
and this disease. In Africa the disease is a widespread heterosex-
ual infection. Through some capricious set of circumstances, 
the first persons infected in the United States were homosexual 
men. HIV is present in semen, vaginal, and cervical secretions. 
The virus is frequently transmitted by heterosexual or male 
homosexual relations, but lesbian transmission is extremely rare 
with only two possible cases reported. It is likely that male-to-
female transmission is more effective than female-to-male 
transmission. The risk of transmission appears to be very high 
during anal intercourse, fairly high during vaginal intercourse, 
and fairly low during oral intercourse. Because the rectal lining 
is more delicate than that of the vagina or mouth and tears and 
bleeds more easily, infection inoculated in the rectal lining 
seems more likely to have direct access to the bloodstream. An 
additional factor that may increase risk of anal infection is that 
semen itself is immunosuppressive if it reaches the bloodstream. 
Fortunately, AIDS is less readily transmitted sexually than 
many other sexually transmitted diseases. Some people can be 
exposed many times and still not contract the infection. How-
ever, some people do become infected after only one or two epi-
sodes of coitus. These differences in susceptibility among 
exposed persons probably relate to three factors: 1) degree of 
infectiousness of the carrier, 2) general state of health of the 
exposed persons (including other concurrent infections), and 
3) genetic susceptibility of the exposed person. These factors are 
probably very important in determining the likelihood of infec-
tion when the exposure is to relatively low doses of vims, such 
as by sexual contact and needle stick. On the other hand, when 
the exposure is to large doses of vims injected directly into the 
bloodstream, ie, when an infected unit of blood is received, 
almost no one is resistant to infection. 
Heterosexual relations 
Regarding heterosexual transmission, in the United States 
women represent only 7% of AIDS cases, and half of these 
women are infected from intravenous drug abuse, not sexual 
relations. In central Africa women comprise 50% of the cases, 
and transmission is almost all sexual. 
In urban areas of central Africa 20% to 88% of female pros-
titutes are infected with HIV heterosexually. However, in the 
United States and Europe, most prostitutes become infected 
from intravenous dmg abuse, since the pool of infected hetero-
sexual men is very small outside the dmg abusing population. 
Street prostitute infection rates of 13% in Detroit and 58% in 
Newark, New Jersey, where there are large numbers of infected 
dmg abusers, are not surprising. There has been to date in the 
United States what would seem to be less cases than expected 
among male customers of female prostitutes. Possible reasons 
for this include health and genetic factors, a lower risk of 
female-to-male transmission, and the American male's frequent 
preference for fellatio. (In Africa sex with prostitutes virtually 
always involves vaginal intercourse.) 
The risk of male-to-female transmission as measured by the 
rate of seropositives among steady female partners of infected 
males has ranged from 7% to 70% in various studies. Inter-
estingly, analyses of these studies show that the men fall into two 
groups: one with a high transmission rate of 40% to 70%, and 
the other with a low rate of 7% to 30% transmission to female 
partners. The high-transmission group includes men who are 1) 
intravenous drug abusers; 2) heterosexual armed forces men 
(who often have acquired the infection from many prostitute 
contacts); or 3) African or Haitian men. The low-transmission 
group includes men who are 1) hemophiliacs, 2) other trans-
fusion recipients, or 3) bisexual. In attempting to explain this 
discrepancy in risk of transmission to female partners, one hy-
pothesis is that the high-transmission group can be characterized 
by a high incidence of other sexually transmitted diseases and/or 
malnutrition or poverty. Whether such a hypothesis is valid is 
unknown. Of concern is that these factors that may lead to a 
higher transmission rate are characteristic of our urban poor. 
The rapid heterosexual spread of HIV in Africa is alarming: 
infection rates of mothers at a well-baby clinic in Zaire increased 
from 1% in 1980 to 5% in 1985 and in prostitutes in Nairobi from 
8% in 1981 to 85% in 1987. Two factors in Africa could acceler-
ate the heterosexual spread: 1) malnutrition and malaria may 
weaken the immune system, making persons more susceptible 
to HIV; and 2) the current raging epidemic of other sexually 
transmitted diseases in Africa may give rise to conditions in the 
genitalia that make an individual both more infectious and more 
susceptible to HIV. Several recent studies suggest that the pres-
ence of genital ulcer disease increases HIV transmission. In 
Africa, chancroid is very common, as well as herpes and syph-
ilis, as a cause of genital ulcers. Even inflammation of the geni-
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tai mucosa due to gonococcal or chlamydial infection may make 
the mucosa more permeable to HIV and lead to an outpouring 
of inflammatory cells, including the lymphocytes and mono-
cytes which are the primary cells that are HIV-infected and 
HIV-infectible. 
A recent preliminary report from Britain suggests increased 
likelihood of HIV infection and progression of HIV disease in 
persons carrying one of the three alleles of group specific com-
ponent (Gc factor, which is the vitamin D receptor present in 
blood and on the surface of cells). Population studies have 
shown that the proportion of persons heterozygous or homo-
zygous for the unfavorable allele is around 15% in whites in 
Europe and the United States versus 60% in blacks in Africa. 
This raises the very alarming possibility that blacks could be 
more susceptible to HIV on a genetic basis. 
Another recently described variable that may influence het 
erosexual (and presumably homosexual) transmission of HIV is 
the level of immune function of the infected person. Transmis 
sion appears greater when immune function is lower, possibly 
due to higher titers of vims in blood and presumably semen. In 
studies by Redfield et al among seropositive heterosexuals in the 
armed forces (almost all male), the percentage of spouses who 
were seropositive was 16% (3/19) when the index case had a nor 
mal number of T-helper cells (> 400/|xL), 25% (2/8) when the 
number of T-helper cells was below 400 but AIDS-related com 
plex (ARC) or AIDS were not present, and 56% (13/25) when 
ARC (as indicated by thmsh) or AIDS were present. This find-
ing has potentially ominous implications. To date, among hemo-
philiacs and even bisexual men, very few spouses and almost 
no children have been infected. Most infected children in the 
United States are offspring of intravenous drug abusers. This 
low incidence of infection in spouses and children of hemo-
philiacs and bisexual men could change over the next five years. 
Since most infected persons show a decline in immune function 
over time, these men may become more infectious to their 
spouses. Also, pregnant women may be more likely to transmit 
HIV to the fetus if their immune function is low. 
Blood transniission 
Transmission of AIDS via blood is a special circumstance that 
accounts for few cases except among intravenous dmg abusers 
and from mother to fetus. If a pregnant woman is infected, there 
may be a 50% chance that her child will be bom infected. The 
risk of transmission of AIDS via blood transfusion is very low, 
probably in the range of one per 60,000 units of blood or less 
with present antibody screening. Transmission of fatal viral hep-
atitis (usually non-A, non-B) is at least six times more frequent. 
Present antibody screening and procedures to discourage high-
risk donors have eliminated almost all transfusion-associated 
HIV transmission. However, it must be understood that a 
number of cases of AIDS among transfusion recipients will con-
tinue to occur due to infection acquired before the antibody 
screening began in the spring of 1985. 
Hemophiliacs represent an exception to the rarity of AIDS 
transmission from blood products. The development of 
lyophilized Factor VIII concentrate, which can be administered 
at home, revolutionized the treatment of hemophilia and enabled 
many hemophiliacs to lead normal or almost normal lives. Un-
fortunately, the preparation of commercial Factor VIII concen-
trate involved the pooling of blood from enormous numbers of 
donors. A severe hemophiliac using Factor Vl l l concentrate at 
home could be exposed in one year to the blood products of up to 
200,000 individuals. Almost all severe hemophiliacs who used 
large amounts of Factor VIII concentrate at home before 1985 
have become infected. Since 1985, the clotting factor concen-
trates have been heat-treated and now are all antibody-screened 
as well. There has been no documentation of transmission from 
heat-treated, antibody-screened products, and transmission 
from products that have been heat-treated but not antibody-
screened is extremely rare. 
Certain blood products carry no risk whatsoever of HIV trans-
mission. These include albumin (because it is pasteurized), 
immunoglobulins of all types (regular gamma globulin, HBIG, 
Rho-Gam, etc), the hepatitis B vaccine, and now the heat-
treated, antibody-screening clotting factors. The fractionation 
process involved in the preparation of immunoglobulins has 
been shown to produce a 15 log reduction in the titer of HIV 
vims. Since the highest titer HIV found to date in human blood 
is lO'* (4 logs), this provides an enormous safety margin. Also, 
steps in the preparation of the original hepatitis B vaccine (which 
was made from blood) kill all HIV so there is no risk. 
Although antibody to HIV is found in many lots of immune 
globulins today, this has not produced even transiently positive 
antibody tests in recipients of intramuscular immune globulin. 
Rarely has there been transient ( ^ 30 days) weak-positive 
ELISA reactivity in persons receiving high-dose intravenous 
immunoglobulins. 
Social contact 
The Centers for Disease Control (CDC) term interaction with 
family, close friends, and co-workers as "casual contact," but 
actually mean intimate contact short of sexual relations. There is 
overwhelming evidence that such contact virtually never trans-
mits HIV. To date, 715 individuals who have lived in the same 
household as someone carrying HIV but who are not sexual 
partners of the infected person or infants bom while the mother 
was infected have been studied carefully. None of these 715 peo-
ple are seropositive. Since half of the household contacts in all 
ofthese studies were children, the fear that school teachers with 
HIV infection will transmit the virus to their students seems 
totally unfounded. 
The first ofthe household studies is an ongoing study through 
Montefiore Hospital in New York City. These AIDS patients are 
mostly poor, Hispanic, intravenous dmg abusers living in very 
crowded conditions in New York City—certainly not an optimal 
situation regarding household hygiene. A total of 199 of these 
household contacts have been studied. Ninety percent of these 
contacts had shared the bathroom and kitchen, 50% had dmnk 
from the same glass or eaten from the same dish before it had 
been washed, 30% to 40% had slept in the same bed (mostly 
children sleeping with their parents) and bathed with the patient, 
10% to 15% used items that might draw blood such as razors, 
toothbrushes, or nail clippers, 83% kissed on the cheek, and 
17% kissed on the lips. That none of these 199 nonsexual house-
hold members is seropositive is strong evidence against close 
personal contact short of sexual relations transmitting HIV. 
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In a second study the AIDS patients were children with trans-
fusion-associated AIDS, most of whom shared toys with their 
siblings. Again, none of 85 household contacts are seropositive. 
Six different groups have looked at 269 family members of 
hemophiliacs, many of whom helped to administer the intra-
venous Factor VIII at home to the patients, and none of these 
individuals is seropositive. Also, none of the other 162 house-
hold contacts in four other studies are seropositive. 
The only report of a seropositive household member involves 
a case from Germany of a seropositive 6-year-old brother of a 
3-year-old boy who died of transfusion-associated AIDS. The 
route of that transmission is unclear. Although the author sug-
gested a bite as a possible cause, the mother stated that the bite 
did not break the skin or cause bruising. More likely another 
route of transmission is possible, including blood mingling or 
even childhood sexual play. 
Regarding teeth bites, in prospective studies there has been no 
documentation to date that bites can transmit AIDS. In the study 
of children with transfusion-associated AIDS, there were 15 in-
stances in which the patient bit a sibling or vice versa, and none 
of the 15 siblings was seropositive. In another study a hemo-
philiac was injured in an automobile accident and suffered brain 
damage which caused him to bite people. He had ARC, his 
mouth was "always dripping with blood and saliva," and he bit 
30 health care workers to the point of leaving scars, yet none of 
these individuals is seropositive. One of our own employees 
who was bitten by an ARC patient is seronegative at 15 months 
after exposure. 
Other methods of transmission 
Organ transplantation—Organ transplantation or donation 
of other body components such as semen carries a risk similar 
to that of a single unit of blood. Current policy is to screen all 
donors for HIV prior to organ transplantation. Thus, future 
transmission via these routes should be exceedingly rare. 
Breast milk—Transmission may occur through breast milk. 
The one reported case involved a woman who after delivery ac-
quired the infection from a blood transfusion. She nursed her 
baby for six weeks, and the baby was subsequently found to be 
infected. The vims has been isolated from breast milk on several 
occasions. 
Tears and saliva—The possible presence of the AIDS vims 
in tears and saliva alarms the general public. What the public 
ignores is that there has been no evidence of transmission by 
these routes. Even though a small amount of vims may be pres-
ent in tears and saliva in only a minority of infected individuals, 
no evidence suggests transmission by these routes. 
Other body fluids—Relatively large amounts of vims may be 
present in cerebrospinal fluid and brain when the central nervous 
system (CNS) is infected. This certainly could present a risk of 
nosocomial transmission, although none has been reported to 
date. The vims is present in small amounts in urine in a minority 
of people but no transmission from this source has been docu-
mented. Cultures from feces have not yet been done because of 
technical difficulties, but the virus could be present in feces. 
There is no evidence of transmission from sweat. 
Insects—There has been no evidence of mosquito or other in-
sect transmission despite the theoretical possibility raised by 
certain laboratory studies. The strongest evidence against mos-
quito transmission is the absence of seropositivity in children 
ages five to 15 years in Belle Glade, Florida, and central Africa 
in areas where 5% to 10% of adults are infected. Children older 
than five and younger than 15 years are likely to have been bom 
before their mothers became infected (since there were rela-
tively few infected heterosexuals in the United States or Africa 
five years ago) and are likely to be too young to be sexually ac-
tive themselves. Yet these are the very individuals who are in 
closest contact with their infected parents and most likely to be 
bitten by the same mosquito. 
Common Misconceptions Regarding 
TVansmission 
The concem about insect transmission of HIV is an excellent 
example of the common error made by laypersons and medical 
personnel who fail to make the critical distinction between the-
oretical and actual routes of transmission. Anyone can dream up 
a thousand different theoretical scenarios for HIV transmission. 
However, one must look to the science of epidemiology, which 
is the study of disease transmission, to find the ways in which the 
infection is and is not really being transmitted among persons in 
contact with HIV-infected individuals. 
Another source of confusion and potential hysteria is the 
CDC's list of AIDS cases by risk factors. At the bottom of the list 
is a group called "no risk identified." The general public often 
assumes that these are persons who contracted AIDS from toilet 
seats, food, etc, or other as yet unrecognized means of transmis-
sion. In fact, there is no evidence that this is so. Indirect evi-
dence suggests that most of these persons have risk factors that 
they are unwilling to admit. This is understandable, given such 
.sensitive subjects as homosexuality and dmg abuse. A minority 
ofthese persons may have been unwittingly infected through 
sexual partners who had risk factors of which they were 
unaware. 
Nosocomial TVansmission 
Although the routes of transmission of HIV and the hepatitis 
B virus are similar, fortunately the nosocomial transmissibility 
of HIV is much, much less. Many health care workers are not 
aware of this low risk of HIV transmission. The few instances of 
transmission have been well publicized, but the denominator— 
namely, how many other health care workers have been exposed 
and remain uninfected—is little known by many people. The 
difference between HIV and hepatitis B transmission is best ex-
emplified by the data to date on needle sticks. In prospective 
studies up to 25% of those with needle sticks from hepatitis B 
carriers have seroconverted, whereas studies to date have shown 
seroconversion in only one of 514 needle sticks from HIV 
carriers. These are data from a compilation of five studies con-
ducted by the CDC, National Institutes of Health, San Francisco 
General Hospital, University of California-Los Angeles, and 
the Communicable Disease Surveillance Centre in London 
(the British equivalent of our CDC), plus six of our health care 
workers who were not part of the CDC study. (Eight other Henry 
Ford Hospital employees are included in the CDC data.) In these 
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studies the exposures were not only needle sticks but other per-
cutaneous exposures, such as scalpel cuts. I will use the term 
needle stick to stand for all percutaneous blood exposures. Of 
importance in the prospective studies was that blood was first 
tested within 30 days of the needle stick, to be sure that the indi-
vidual had not previously acquired HIV, and was then tested 
again three months or more after the needle stick. 
In addition to the one seroconversion from needle stick in the 
prospective studies of 514 individuals, three other anecdotal re-
ports of seroconversion from needle stick have been reported in 
the world to date. All four of these reported seroconversions in-
volved nurses, one each from the United States, Britain, France, 
and Martinique. Two of these nurses experienced inadvertent in-
jection of blood in addition to the needle stick. Since there is no 
denominator for the three anecdotal reports, our best guess as to 
the denominator, and hence the risk, for needle stick transmis-
sion is from the five prospective studies previously cited: 
approximately one in 500 with a 95% confidence interval well 
below 1%. 
This striking difference between hepatitis B and HIV trans-
mission from needle stick is probably due to the enormous 
amount of hepatitis B vims in the blood versus the small amount 
of HIV in blood: hepatitis B carriers have 10"* to 10" viral parti-
cles per mL whereas HIV carriers have 10' to 10" (usually 10' to 
10^ ) viral particles per mL of blood. 
In areas with a high incidence of HIV infection in North 
America and London, prospective studies of health care workers 
without risk factors in their private lives have shown only one 
seropositive individual (the American nurse who had suffered a 
needle stick) among the 2,499 tested. Among dental workers 
(75% dentists, 60% of whom practiced in high-risk areas), only 
one of 1,795 was found to be seropositive, and this case is still 
under investigation to eliminate risk factors in the person's 
private life. This exceedingly low incidence of seropositivity 
among dentists is of particular interest since it is well known that 
dentists have been at a higher risk of hepatitis B than physicians. 
Individual case reports of five other instances of transmission 
through patient care have been documented in the world. These 
instances apparently involved exposure of dermatitic skin to 
blood in three cases, blood in the mouth in one case, and in the 
last case extraordinarily poor hygiene on the part of the care-
giver in the face of prolonged and intense exposure to blood and 
body fluids. Three of the five instances occurred among health 
care workers while on the job; in two of these instances the 
health care workers were not using the recommended precau-
tions, and in the third case a very unusual accident occurred. 
The other two cases involved caregivers in the home, dealing 
with persons not recognized to be infected. One of these in-
stances involved a mother who was a paramedic and who cared 
for her infant at home. The child was bom with a congenital in-
testinal disorder requiring colostomy and causing heavy bleed-
ing. The infant became infected from the transfusions, which 
went unrecognized for months. The mother was found to have 
seroconverted at the time of blood donation. Despite being a 
health care worker, the mother exercised very poor hygiene 
and usually did not wash her hands for some time after getting 
blood or feces on them. The other home care instance involved a 
British woman with extensive eczema on her hands and arms 
who cared for an ill neighbor until he died. The diagnosis of 
AIDS was unsuspected until postmortem examination. 
To put the risk of these worrisome non-needle stick exposures 
in perspective, we need to consider the data on: 1) mucosal ex-
posure in prospective studies, and 2) the previously mentioned 
serosurveys of health care workers. Regarding mucosal ex-
posure to blood and body fluids, the five prospective studies pre-
viously mentioned also looked at such exposure and found no 
seroconversions in 493 individuals. Of the 4,294 medical and 
dental health care workers serosurveyed, only two were 
seropositive, one of which involved a needle stick. Many of 
these individuals doubtless had taken care of HIV-infected indi-
viduals without realizing it, and many probably at times had 
dermatitis or breaks in the skin. 
Another way of viewing the health care worker risk is to see if 
health care workers are disproportionately represented among 
the persons in the "no identified risk" in the United States: in 
fact they are not. Health care workers make up about 5% of that 
group and 5% of the US population in general. Even in Zaire 
where the seropositivity rate among inpatients is very high and 
where hospital hygiene is very different (eg, nurses have to wash 
used needles before resterilization), the seropositivity rate 
among health care workers is the same as that of the general pop-
ulation, around 5%. This suggests that the increase in risk must 
be very slight, even in Zaire. 
What does happen in the rare instances where there is trans-
mission to health care workers? These instances may represent 
either patients who are particularly infectious (ie, those who 
have a high titer of circulating virus and/or a more infectious 
strain of vims) and/or health care workers who are particularly 
susceptible to HIV, possibly on a genetic or general health basis, 
or more likely a combination of these factors. 
Regarding home care, many of the 715 household contacts 
mentioned previously helped care for AIDS patients at home, 
usually for some time (often years) before the diagnosis was 
made, and thus no special precautions were being used. This 
included many family members of hemophiliacs who helped 
administer infected intravenous Factor Vl l l at home. 
Magnitude of the Epidemic 
Over 36,000 people in the United States and about 360 indi-
viduals in Michigan as of June 1987 have had full-blown AIDS. 
With estimates of 50 to 100 carriers for every case of full-blown 
AIDS, we may have 2 million in the United States and at least 
20,000 in Michigan who are carrying HIV infection. Among 
the persons in high-risk groups, the infection rates are astro-
nomical . Of the homosexual or bisexual men in most large urban 
areas, 30% to 70% are already infected. Michigan has been for-
tunate in that the epidemic has been slower to spread, probably 
because Detroit is not a tourist mecca. A study one year ago sug-
gested that only about 20% of Detroit-area homosexual or bisex-
ual men were infected. The infection rate for intravenous dmg 
abusers also ranges from 30% to 70% in many East Coast urban 
areas, yet is only 5% to 10% in the Detroit area. However, this is 
no cause for complacency. Two other areas with large numbers 
of intravenous dmg abusers per capita. New York City and (curi-
ously enough) Italy, have had astronomical increases over a five-
year period in infection rates in intravenous drug abusers. In 
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both these areas HIV infection rates in intravenous dmg abusers 
went from 5% to 10% in 1980 to 60% to 70% five years later in 
1985. Thus, one can anticipate that by 1991, 60% to 70% of the 
estimated 30,000 to 40,000 intravenous dmg abusers in Detroit 
will be infected. This also will lead to infection in at least half of 
the sexual partners, and one quarter of their babies, which 
means there may be hundreds of babies with AIDS in Detroit by 
1991. Among hemophiliacs, because the Factor VIII concentrate 
was nationally distributed, the infection rates are the same 
throughout the United States. For those using that product at 
home before 1985, infection rates range from 70% to 100%. 
If we had a vaccine tomorrow, we could not help many of the 
people in the high-risk groups because they are already infected. 
AIDS is the leading cause of death among gay men in urban 
areas. Because AIDS strikes young people, it has become the 
fourth leading natural cause of years of life lost in the United 
States behind only cancer, heart disease, and stroke. For a dis-
ease that was unknown six years ago, this is incredible. Central 
Africa faces a holocaust from this disease. In central Africa 5% 
to 20% of the general population are already infected with the 
vims, and public education campaigns have just started. Esti-
mates are that there may be 5 to 10 million infected persons in 
Africa already, and these rates continue to escalate rapidly. Esti-
mates for the United States by the year 1991 include: 1) more US 
citizens will have died of AIDS than have died in all the wars 
since World War I , 2) in that year for the first time AIDS will kill 
more people than are killed in motor-vehicle accidents, and 
3) the number of infected persons in the United States could be 
as high as 5 to 10 million. 
Symptoms 
The CDC has devLsed a classification system for HIV infec-
tion based on clinical manifestations. An outline of this system 
is given in the Table (also see the Suggested Reading list, #6). 
Investigators are attempting to use this system for future studies. 
However, some commonly used terms such as ARC are not em-
ployed in the CDC system. In the following section commonly 
used terms will be explained along with reference to the CDC 
system terminology. 
Persons infected with HIV may have symptoms ranging from 
none to fatal. The symptoms may occur at any time after infec-
fion, anywhere from one week to over seven years later. An un-
known percentage of persons have an acute self-limited illness 
one to eight weeks after infection (CDC group 1). The acute ill-
ness may be "mono-like" with fever, myalgias, lymphadeno-
pathy, rash (in 50%), diarrhea (in 30%), or may be neurologic 
(aseptic meningitis, acute encephalitis, and Guillain-Barre syn-
drome have been reported). These manifestations will often 
resolve when they result from initial infection and are not 
to be confused with the progressive neurologic disease seen 
later in the course of HIV infecrion (CDC group IV-B). 
Between one-third and two-thirds of HIV-infected persons will 
develop lymphadenopathy at some time after infection, which 
may remain for years. This is termed persistent generalized 
lymphadenopathy (PGL) in the CDC classification (CDC group 
III). Lymphadenopathy will often disappear if the total number 
of lymphocytes in the body gets very low, ie, just before or at the 
Table 
Centers for Disease Control Classification 
System for HIV Disease 











Group I Acute infection: Within one to two 
months of exposure 
••Mono"-like or central nervous system 
Group II Asymptomatic 
Group III Persistent generalized lymphadeno-
pathy (PGL) 
Group IV A. Constitutional symptoms: fever, 
weight loss, diarrhea 
B. Neurologic disease 
C. Secondary infections; 
C-I. CDC-AIDS infections 
C-2. Other specified infections: 
thrush, zoster, tuberculosis, hairy 
leukoplakia, nocardia, recurrent 
salmonella bacteremia 
D. Secondary cancers: 
CDC-AIDS tumors: Kaposi's sarcoma, 
certain lymphomas 
E. Other conditions: 
infections, cancers or symptoms not in 
A through D 
onset of AIDS, Other nonspecific symptoms such as fever, night 
sweats, weight loss, and diarrhea are common as immune func-
tion gets low, but may occur transiently in those with normal 
immune function. 
The term ARC (AIDS-related complex) unfortunately has no 
generally agreed upon definition. Some use the term for any 
clinical manifestation of HIV infection short of full-blown 
AIDS, I prefer to limit that term to those with severe symptoms, 
prodromal infections, or severe immune deficiency as 
manifested by T-helper cell counts under 200/mm\ The term 
"wasting syndrome" applies to patients with severe fever, 
weight loss, and diarrhea, which inevitably leads to AIDS (CDC 
group IV-A). 
Certain infections, especially if recurrent, should raise the 
suspicion of HIV infection (CDC group IV, C-2). These infec-
tions have been called "prodromal infections" because they 
seem to carry a relatively high risk of progression to full-blown 
AIDS. This risk may be as high as 50% to 80% over the next one 
to two years. Prodromal infections include: 1) thmsh, especially 
that which occurs in adults not receiving antibiotics or that 
which recurs after treatment; 2) zoster; 3) tuberculosis; 4) oral 
hairy leukoplakia, a condition resembling thmsh which causes 
ribbed, white lesions on the lateral tongue margins or opposing 
cheek and is KOH-negative; 5) recurrent salmonella bacteremia; 
and 6) nocardiosis. The latter two are much rarer. In contrast to 
the onset of opportunistic infections, which is usually preceded 
by some waming sign such as the wasting syndrome or thmsh, 
some individuals who develop Kaposi's sarcoma are often 
asymptomatic and simply notice the skin lesion. Many of them 
have had lymphadenopathy. 
Tuberculosis itself—ie, infection with Mycobacterium tuber-
culosis (not to be confused with infection due to the atypical 
mycobacterium, Mycobacterium avium-intracellulare, which is 
common in full-blown AIDS)—is much more frequent among 
Henry Ford Hosp Med J—Vol 35, No 1, 1987 AIDS Update—Fisher 11 
HIV-infected people. It may occur either before or after the 
development of full-blown AIDS. Persons who were tuberculin-
positive prior to the onset of HIV infection are very likely to 
develop active tuberculosis as immune function declines. Since 
there is a higher incidence of tuberculin positivity among urban 
intravenous dmg abusers and foreign-bom persons such as Hai-
tians, one sees a concentration of HIV-associated tuberculosis in 
New York City, Newark, and Miami, and such can be antici-
pated in Detroit as our intravenous dmg abuser HIV-infection 
rate climbs. Tuberculosis represents the one possible public 
health threat of HIV infection that is airborne. Fortunately, the 
tuberculosis seen is usually of low or no contagiousness since 
cavitary disease is very rare. The pulmonary manifestations are 
usually atypical of adult reactivation disease: forexample, hilar 
lymphadenopathy and infiltrates typical of primary disease 
(even though not primary) or miliary disease. Often the tuber-
culosis is extrapulmonary involving lymph nodes only. 
The four major neurologic manifestations of HIV infection 
are: 1) encephalopathy, of which the most common form is 
chronic and known as AIDS dementia which affects 50% of per-
sons with full-blown AIDS; 2) myelopathy with ataxia and 
incontinence; 3) aseptic meningitis which may be chronic and 
recurrent; and 4) peripheral neuropathies including acute in-
flammatory polyneuropathies such as mononeuritis multiplex, 
distal symmetric neuropathies similar to those seen in diabetes, 
or cranial neuropathies (CDC group IV-B). 
HIV-infected persons often suffer from an increased inci-
dence of common skin disorders especially as immune function 
declines. These include seborrheic dermatitis (which often be-
comes very severe on the face in full-blown AIDS), folliculitis, 
fumnculosis, acne, dry skin, dermatomycoses, and nonspecific 
rashes. These skin disorders tend to be stubborn and recurrent in 
HIV-infected persons. 
Phenomena of immune dysregulation in HIV infection in-
clude frequent adverse drug reactions, blood cell dyscrasias 
(thrombocytopenia, leukopenia, and anemia), circulating im-
mune complexes, and lupus-like abnormalities (lupus anti-
coagulant, antinuclear antibodies). In fact, almost any disorder 
could be a manifestation of HIV infection. Thus, we can now 
say of HIV infection what was once said of syphilis: to know 
AIDS is to know medicine. 
The diagnosis of AIDS itself is made when a person is diag-
nosed as having one of the 12 opportunistic infections (CDC 
group IV, C-l), two tumors (CDC group IV-D), or lymphoid in-
terstitial pneumonia in an infant (CDC group IV, C-1), These are 
the official CDC criteria for AIDS. Plans are to add to these cri-
teria the wasting syndrome, AIDS dementia, and, in infants, 
certain combinations of severe bacterial infections. It is impor-
tant to reserve the term AIDS for persons meeting these criteria 
since only these individuals have a prognosis that is inevitably 
fatal. 
Tumors named in the criteria for full-blown AIDS include not 
only Kaposi's sarcoma and primary CNS lymphoma, but also 
non-Hodgkin's lymphomas of high-grade B-cell types i f a 
patient is seropositive. These are usually histopathologically 
described as either diffuse undifferentiated, large cell, Burkitt's 
orBurkitt's-like lymphoma, or immunoblastic sarcoma. The 
recognition of AIDS-associated lymphomas means HIV testing 
should be perfonned on most persons with such tumor types. 
Knowledge of HIV infection is critical regarding management 
of the tumor and prevention of transmission, especially to sex-
ual partners. At present, HIV lymphomas tend to be very 
aggressive, and the patient will die of other manifestations of 
AIDS if not the tumor itself. Therefore, the "no-treatment 
option" must be offered. An extremely high incidence of oppor-
tunistic infection must be anticipated whether or not treatment 
is given. 
It is important to do HIV-testing on all patients with Kaposi's 
sarcoma, even if they are elderly men of Jewish or Mediterra-
nean extraction. One of the most interesting aspects of AIDS is 
that the incidence of Kaposi's sarcoma is much higher in gay 
men (20% to 40%) than in any other risk group (2% to 10%) or 
even in Africans (16%), The manifestations of AIDS otherwise 
seem very similar in all risk groups. Hypotheses for this dif-
ference in the incidence of Kaposi's sarcoma involve two possi-
ble cefaclors for Kaposi's sarcoma among gay men: the higher 
use of inhaled nitrites, and the higher incidence of reexposure to 
cytomegalovims via semen among gay men. 
Serologic Testing 
Of all people infected with HIV in the United States, at pres-
ent only about 1% to 2% have full-blown AIDS. Only one-third 
ofall those infected have some symptoms, signs such as obvious 
lymphadenopathy, or laboratory abnormalities such as leuko-
penia or thrombocytopenia. The remaining two-thirds are 
asymptomatic and have no obvious abnormalities on physical 
examination or routine laboratory testing. The only way to de-
tect these asymptomatic carriers is through serologic testing for 
antibodies to the AIDS vims. Two methods of HI V-antibody de-
tection are commonly used. The screening test is done by the 
ELISA method, which is performed at Henry Ford Hospital and 
many other large laboratories. A preliminary estimate of the 
likelihood of a positive ELISA being a tme positive can be made 
from how strong a positive it is. In our laboratory if the sample/ 
cut-off ratio is greater than five, this is a strong positive and is 
very likely to be a true positive. The Western blot method of 
antibody detection is used as the backup or "confirmatory" test. 
The Westem blot is much more difficult and expensive and is 
done only by a few reference laboratories. In Michigan it is done 
by the Michigan Department of Public Health in Lansing, and 
results take four to six weeks. The ELISA and Westem blot can 
be thought of as roughly similar to the VDRL and the specific 
treponemal tests (such as FTA) for syphilis testing. However, the 
sensitivity and specificity of the ELISA is much higher than that 
of the VDRL, ranging from 95% to 99%. 
The blood test for HIV antibodies is unlike any other test that 
a physician orders. This test should never be ordered without the 
patient's consent, except under the most extreme circumstances, 
because a positive result is a catastrophic event in the person's 
life. It is more devastating than a test for cancer or any other po-
tentially fatal disease because no other disease carries the stigma 
that HIV infection carries. Persons have committed suicide as a 
result of this test, and any patient faces potential abandonment 
by family, friends, lover, as well as loss of job and insurance. It 
is absolutely essential that the physician determines the patient's 
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psychological support system before ordering the test. If the pa-
tient says there is no one with whom he or she can discuss the 
test result—ie, no family, friend, pastor, volunteer support 
group, or professional counselor—it is best to defer testing until 
support is available. In the meantime the patient is advised to 
behave as if he or she is positive. Before testing, all patients 
must be counseled about the limitation of antibody methods: 
I) false-positives and false-negatives; 2) that even though the 
presence of antibodies does not prove that the infectious agent is 
present, it must be assumed that any antibody-positive person is 
presently carrying HIV; and 3) that antibody positivity gives no 
information about the duration of infection or prognosis. The 
patient must be counseled about the civil rights issues, particu-
larly regarding homosexuality. Most heterosexuals are unaware 
that in Michigan homosexuals can lose their jobs and be refused 
housing just because they are homosexual. Although it is illegal 
to discriminate on the basis of race, sex, or religion, discrimina-
tion based on sexual preference is not illegal except in three cit-
ies in Michigan (Detroit, Ann Arbor, and East Lansing), which 
have local ordinances prohibiting such discrimination. Thus, 
known homosexuals can be fired whether or not they are HIV-
positive, Moreover, since medical confidentiality is at best a 
loose term, a person known to his/her friends or co-workers as 
antibody-positive may become an instant leper Some protection 
is offered in that the Michigan Department of Civil Rights has 
declared HIV infection a handicap. Nevertheless, attempts have 
been made to fire or refuse employment to HIV-positive per-
sons. Because of these concems, patients should be made aware 
that a number of alternate test sites offer anonymous testing. 
Patients may call Wellness Networks, our local AIDS organiza-
tion, to obtain the locations. The Wellness Networks telephone 
number is toll-free (1-800-872-AIDS) throughout Michigan, At 
the altemate test sites, pretest and posttest counseling is given, 
the results do not go into the patients' medical records, and re-
sults are not given until the Westem blot test result is received. 
Anonymous screening is often the best option for persons con-
cemed about confidentiality, including heterosexuals at a low 
risk of HIV disease. For the latter, a positive ELISA test is usu-
ally going to be a false-positive. With anonymous testing the 
false-positive ELISA does not become part of the patient's 
permanent medical record (and thus a subject of misinterpreta-
fion indefinitely). 
The predictive value of a test, that is, the likelihood that a 
positive is a tme positive and a negative is a tme negative, is a 
particularly critical issue regarding HIV testing. The formula 
used to calculate predictive value (Bayes' theorem) contains a 
critical third variable in addition to the sensitivity and specificity 
ofthe test. The critical third variable is the estimated prevalence 
of the disease in the population being tested. There is no way 
around the fact that the predictive value of a positive test will be 
low in a low-risk group, no matter how good the test is. For this 
reason screening of low-risk people on a large scale is not gener-
ally recommended unless they are going to be donating body 
parts to other individuals. On the other hand, the predictive 
value of a positive result is very high in high-risk groups, but in 
those groups the predictive value of a negative is somewhat 
lower In fact, it is best to suggest that persons who have been on 
the receiving end of anal semen from a known infected person 
assume that they are positive indefinitely even though their 
screening test may be negative. 
Management of Seropositive Persons 
What should we tell people whose test results (both ELISA 
and Westem blot) seem to be tmly seropositive? Experimental 
studies indicate that the majority of these people are still in-
fected and will likely remain so for life. Moreover, the sen-
sitivity of our current culturing and antigen-detection methods 
(all of which are experimental at present) is suspected to be 
rather low. Latently infected cells could start producing infec-
tious vims at any time. Thus, we have to assume that anyone 
who has ever been infected is still infected. No one knows why 
some persons will develop the fatal disease while others do not. 
In terms of predicting the likelihood of development of AIDS, 
time appears to be a major factor The longer a person has had 
the infection, the greater the risk they will progress to full-blown 
AIDS. Certain prodromal infections such as thmsh, zoster, and 
tuberculosis indicate a higher risk of progression. The single 
laboratory parameter that most closely correlates with the risk of 
AIDS is the absolute number of T-helper cells. The T-helper (or 
T4) lymphocyte is the key cell in the immune system. Normal 
numbers are 400 to 1700 per (JLL. Persons with less than 400 
T-helper cells are at steadily increasing risk. Opportunistic in-
fections become likely when the helper cell count reaches 200 or 
less, although some individuals can go a year or two at these 
levels without developing AIDS. On the other hand, Kaposi's 
sarcoma can develop with higher, occasionally even normal, 
numbers of T-helper cells. The T-helper-suppressor ratio 
appears not to be as important as the number of helper cells. 
However, there is some evidence that persons with very large 
numbers of suppressor (T8) lymphocytes (which results in a 
disproportionate lowering of the ratio) may be at greater risk. 
Usually full-blown AIDS does not develop without premonitory 
clinical or laboratory deterioration. If patients who are HIV-
seropositive are followed, a progressive decline is seen in the 
number of T-helper cells in many of these individuals over a 
period of time, and the physician can then inform the patient 
when the risk of AIDS becomes significant. Knowing the 
T-helper cell count is clinically useful in other ways also: for ex-
ample, a seropositive individual with cough and fever and 500 
T-helper cells is very unlikely to have Pneumocystis pneumonia 
whereas someone with similar symptoms and 150 T-helper cells 
is very likely to have Pneumocystis pneumonia. 
Another recently described predictive factor for high risk of 
AIDS over the succeeding one to two years is the appearance of 
circulating antigen to the core ofthe vims (p24 antigen) and dis-
appearance of antibody to the core (p24 antibody). Assays for 
p24 antigen and antibody will soon be on the market. 
Based on experience with other infections, certain conditions 
that contribute to a poor general state of health may make a per-
son more susceptible to HIV. In addition, acceleration of HIV 
disease may result from repeated reexposure to other long-last-
ing viral infections such as cytomegalovims, Epstein-Barr 
vims, and the viral hepatitides. In vitro, these vimses produce 
long-lasting activation of the T-helper cells, which makes these 
cells much more susceptible to infection with the HIV virus. 
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Persons with many sexual partners or repeated blood exposure 
have a much higher rate of reexposure to these ubiquitous viral 
agents. Certain proteins of these other vimses may "tum on" 
HIV. These proteins mimic the tat gene of HIV, which acceler-
ates HIV replication. 
Medical Management of Seropositive Persons 
Seropositive individuals are seen for an initial evaluation. A 
history, physical examination, and the following tests are done: 
complete blood count with differential, sedimentation rate, 
platelets, and SMAC; urinalysis; helper/suppressor counts; skin 
tests for tuberculosis, histoplasmosis, coccidioidmycosis, 
and two controls; serology for toxoplasma, hepatitis B (includ-
ing core antibody), herpes viruses (herpes simplex, 
cytomegalovims, Epstein-Barr vims, and varicella-zoster), and 
syphilis (including VDRL and a treponemal test); and chest 
x-ray (particularly to rule out hilar adenopathy and tuber-
culosis). The skin tests and serologies serve to indicate infec-
tions to which a person may have been exposed in the past that 
can reactivate if the immune functions decline. These tests are 
more reliable if done when immune function is good. When im-
mune function declines, most persons become anergic and anti-
body tests may become negative. Indicated vaccines and INH 
prophylaxis, if tuberculin positive, are offered. Follow-up is 
every six months if persons are feeling well and have normal 
numbers of T-helper cells; follow-up is every three months if 
persons are symptomatic or have low numbers of T-helper cells. 
At each visit a history and brief physical examination (with spe-
cial attention to mouth, skin, lymph nodes, and spleen) are 
done. Laboratory studies include complete blood count with dif-
ferential, sedimentation rate, and helper/suppressor counts. 
Presently zidovudine (formerly known as AZT) is available to 
persons with ARC with less than 200 helper cells. This is an-
other good reason for persons at risk to be tested and followed, 
since some persons with less than 200 helper cells are 
asymptomatic and may be passing up an opportunity for life-
prolonging medication. 
Advice to seropositive persons is as follows: 
1, Maintain the best possible state of health. Get good nutri-
tion, exercise, and adequate rest; reduce or eliminate drugs, 
cigarettes, and alcohol; and manage stress. Of these, stress man-
agement is often the most difficult. Persons who are seropositive 
without AIDS are actually under greater stress than persons with 
AIDS because of the uncertainty of their position. The feeling of 
carrying a time bomb is poorly tolerated by human beings. 
Many persons can benefit from professional counseling or 
volunteer support groups such as those run by Wellness 
Networks, Inc. 
2, Use safe sex precautions. These precautions not only pro-
tect others but also the patient from acquisition of more HIV 
(which may not be helpful) and from reexposure to other vimses 
such as cytomegalovims, herpes simplex, Epstein-Barr vims, 
and hepatitis B, which could accelerate the HIV process. Safe 
sex should be implemented even when both partners 
are seropositive. 
3, Take indicated vaccines. These include vaccines for pneu-
mococcus, influenza, hemophilus type B in children and hepati-
tis B for those individuals who are hepatitis-B-seronegative. 
Salk inactivated polio vaccine and diphtheria-tetanus toxoid are 
also safe. Live viral vaccines should be avoided: yellow fever, 
oral polio, and measles, mumps, and mbella. The only excep-
tion is asymptomatic seropositive children with normal immune 
functions who may do better with these live viral child-
hood vaccines, since to date no adverse complications have 
been reported. 
4. Get regular checkups. This also enables the individual to 
be alert to the possible availability of antiviral or immune stim-
ulant therapy in the future. 
Prevention 
The health care setting 
Blood and body fluid precautions, the same as for hepatitis B, 
are recommended. This involves the use of gloves for drawing 
blood and touching mucous membranes or open sores. Gloves 
are all that are needed in most routine clinic visit settings. If 
there is a good possibility of aerosolization of blood, urine, 
feces, exudates, or respiratory secretion or saliva that contain 
observable (visible) amounts of blood, then full garb with mask, 
gown, gloves, and eye protection is indicated. These situations 
are likely during certain dental or endoscopy procedures, 
surgery, autopsies, and occasionally suctioning. If soiling of 
clothes with blood, exudates, urine, or feces is likely during ex-
aminations or nursing care, gowns are indicated. Many needle 
sticks are a result of recapping. Therefore, the most important 
measure in preventing needle sticks is the placement of imper-
vious needle containers in every inpatient room and clinic exam-
ination room. 
The AIDS vims is readily killed by all common disinfectants, 
most rapidly by chlorine. It is likely that even soap and water 
effectively inactivate the virus with regard to transmission 
potential, ie, reduce the amount of vims to such low levels that 
transmission is not possible. No evidence suggests transmission 
from environmental surfaces. Although all viral particles do not 
die immediately on exposure to air (the titer decreases about I 
log every nine hours and the usual amount of vims in body fluids 
i s « I to 2 logs), there is too little virus present on environmental 
services to be effectively transmitted. Often quoted laboratory 
studies which show prolonged survival of the vims on environ-
mental surfaces are unrealistic, since the amount of vims used 
was much larger (eg, 7 logs) than that found in nature. If blood 
splashes on a person, the most important action is to wash it off 
promptly. What is used to wash it off is not critical. If blood 
splashes in the eye, the eye should be rinsed with copious 
amounts of water. 
The aim of the Michigan Society for Infection Control and the 
Michigan State Medical Society Task Force on AIDS education 
is to get health care providers to gradually phase into "Universal 
Blood Precautions." This means the use of such precautions for 
all patients regardless of whether they are known carriers of HIV 
or hepatitis B, Any other policy is unrealistic if we are trying to 
prevent as many blood-borne infections as possible. The ap-
proach of testing all hospital admissions or clinic patients for 
HIV (or hepatitis B) is a naive one, although such an approach is 
the desire of many physicians these days. This approach ignores 
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several important realities: 1) testing misses some HIV-infected 
persons, especially within the first one to three months after in-
fection (and physicians are also poor at guessing which patients 
are likely to be in high-risk groups); 2) HIV testing of all hospi-
tal admissions would be very costly (the estimate for Michigan 
alone is $35 million per year); 3) it is extremely likely that there 
are other serious blood-bome infections of which we are not yet 
aware; and 4) testing frequendy leads to situations where health 
care workers are overly cautious with certain patients and care-
less with other patients—in other words, testing can lead to a 
false sense of security. It is much better to tighten up technique 
overall and to have a healthy respect for all blood and body 
fluids. Any other approach is naive and unrealistic. 
Home precautions 
Good hygiene is the principle precautionary measure. Items 
that might draw blood (eg, razor, toothbmsh, nail clippers, en-
ema equipment) should not be shared. Spills of blood and body 
fluid should be cleaned up promptly. A one-tenth solution of 
household bleach or other disinfectant such as Lysol is most ef-
fective. Disposable gloves are desirable for handling blood and 
body waste. If gloves are unavailable, emphasis should be on 
washing hands promptly if they become contaminated. In gen-
eral, dishes and clothes can be washed in hot soapy water; bleach 
is not necessary. Household members should be informed of the 
results of studies on household transmission: none of 715 house-
hold members were infected, even when no special precautions 
were used. This indicates an extremely low risk of household 
transmission. 
Intravenous drug abuse 
We need many more dmg treatment facilities, since waiting 
lists for dmg programs are weeks to months. If persons cannot 
stop using dmgs, they should not share needles or other "works" 
(such as "cookers"). If they cannot stop sharing "works," they 
should be taught to clean them with alcohol or a 1:10 dilution of 
household bleach. Intensive public information campaigns 
should be addressed to the sexual partners of dmg users, pro-
moting use of condoms and avoidance of pregnancy if one has a 
seropositive partner. 
Sexual precautions 
The following are our current best guesses as to the risk of 
each sexual activity: 
1. 100% safe: 1) self-masturbation, and 2) mutually monog-
amous relationship since 1977 with partner who is not infected. 
2. Probably safe: 1) Mutual masturbation (if no open sores on 
hands or genitals; if so, use disposable gloves), and 2) kissing of 
non-oral, non-anogenital areas of body (ie, kissing erogenous 
zone where there is intact skin such as ears, neck, breasts, etc). 
3. Possibly safe: sexual kissing (ie, tongue-to-tongue 
kissing). 
4. Very low risk: 1) fellatio with condoms, and 2) cunnilingus 
using dental dam (a piece of mbber that is held over the vulva, an 
activity which most persons find very awkward). 
5. Low risk: 1) vaginal or anal coitus using condom and non-
oxynol-9-containing spermicide (as backup in case of condom 
breakage), 2) fellatio without ejaculation, and 3) cunnilingus. 
6. Low-intermediate risk: fellatio with ejaculation and with-
out condom. 
7, High risk: Unprotected vaginal or anal coitus. 
No transmission has yet been documented from sexual 
kissing. Nevertheless, some concern remains especially for 
long-term heavy exposure as occasionally there may be small 
amounts of blood in saliva. Couples where one partner is in-
fected can be counseled to minimize tongue-to-tongue kissing 
and spend more time kissing erogenous zones where there is 
intact skin. 
HIV does not pass through latex condoms (natural skin con-
doms may occasionally leak). Ideally, condoms should be 100% 
protective. In actuality the failure rate with condom use for preg-
nancy is about 10% per year and is probably of similar magni-
tude for HIV. The reasons for failure are mechanical. Patients 
must be educated to condom use so these errors can be avoided. 
If meticulously used, condoms should be extremely protective. 
The reasons for condom failure include the following: 
1, Failure to use condoms properly (eg, not putting them on 
until just before ejaculation, their coming off due to failure to 
hold them on during withdrawal, or failure to withdraw before 
erection subsides), 
2, Breakage (due to poor quality, deterioration from heat and 
age or use of oil-based lubricant such as Vaseline; attempts 
to reuse same condom; failure to eliminate air pockets under 
condom after putting it on; or failure to allow a space at the tip 
for ejaculation). 
3, Failure to use them on all occasions. 
The spermicide nonoxynol-9 kills HIV and many other sexu-
ally transmitted pathogens in the test tube. It is the main ingre-
dient in most over-the-counter contraceptive foams, creams, and 
suppositories marketed for women and in some lubricants now 
being marketed for gay men. Concentrations of 1% should be 
adequate. Use of the spermicide provides some backup in case 
of condom failure. Some condoms are coated on the outside 
with spermicide, but it is advisable to use more spermicide. 
Spermicide should be inserted in generous amounts in the va-
gina or anus. A small amount of spermicide should be placed in 
the tip of the condom: enough to spread over the penile head but 
not so much that it oozes up the penile shaft causing the condom 
to slip off. The presence of spermicide on the inside of the con-
dom tip has been shown to offer additional protection in case of 
condom breakage. 
Physicians must strongly encourage celibacy or mutually 
monogamous relationships. Yet, at the same time, physicians 
must acknowledge the realities of sexuality, that most people in 
our society have at times had premarital, nonmarital, or extra-
marital sexual relations. Unless the physician feels that death is 
an appropriate punishment for such activities, the physician 
must help patients leam how to make sex safer. Society must 
work toward a mutual attitude that persons who have coitus out-
side of safe, mutually monogamous relationships without using 
condoms are regarded as careless persons who care little for 
their own health and less for the health of others. The biggest 
challenge is instilling this attitude in our young people, who tra-
ditionally see themselves as invulnerable and immortal. Con-
dom ads on television may be distasteful to many people, but 
most people would find it more distasteful to see their children 
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or grandchildren get AIDS, The widespread use of condoms 
will have significant benefits in other areas, particularly in the 
reduction of other sexually transmitted diseases and unwanted 
pregnancies. Given the realities of human sexuality, the condom 
is our most important weapon in the fight against AIDS, 
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